National Antimicrobial Resistance Monitoring System for Louisiana

NARMS增强和加强抗生素耐药性的合作协议计划 零售食品样本的监测 机构资助机会编号：PAR-16-099 路易斯安那州 项目摘要 食用动物过度使用抗生素会导致抗生素的出现。 零售肉制品中的抗药性细菌。这反过来又会导致对抗生素产生耐药性的感染 人类。零售肉类计划监测零售肉类产品中抗生素耐药性的趋势。 IDES的工作人员将每月购买80个零售肉类样品，分成两部分 每次旅行抽样5家商店。以下商品将在每家商店购买：5只鸡 部分，2个火鸡末，1个猪排，1个牛肉末。同一商品的不同品牌 在每个商店都能买到。如果这是不可能的，具有不同批次代码的物品或由 日期将被购买。这些物品将从杂货店的商店购买 抽样清单。肉类样本将于#年运往国家公共卫生实验室。 用于按协议进行处理和测试的巴吞鲁日。分离的沙门氏菌和弯曲杆菌 将被运往FDA进行NARMS测试。将对沙门氏菌分离株进行PFGE 国家实验室和模式将被上传到PulseNet。IDES工作人员和实验室人员的意愿 维护NARMS日志，并将其提交给FDA。他们还将维持FDA 路易斯安那州分离株的季度结果，并将它们与路易斯安那州的结果进行比较，以提高准确性和 质量控制。 在本赠款周期的头12个月，预期成果是继续 每月购买、加工和检测80个肉类样品，并继续发货 对FDA进行NARMS检测的分离物。预期产出包括扭亏为盈的减少 从沙门氏菌分离到模式上传到PulseNet的时间和抗生素的增加 关于沙门氏菌和弯曲杆菌的耐药性数据将与FDA的其他州的数据一起使用。 在五年的项目期内，预期的产出是成功的零售肉类 路易斯安那州计划和FDA NARMS的质量零售肉类监测数据 除了他们从其他州接收的数据之外，还可以使用。高质量数据的这种增长可以帮助 影响有关抗菌药物使用的政策。五年期间的预期成果 包括：1)成功完成了80只肉类的采购、加工和检测 每个月的样品。2)减少了从沙门氏菌分离到检测的周转时间 国家PFGE实验室和模式上传到PulseNet，这可能会导致疫情增加 调查并解决零售肉制品中的沙门氏菌问题。3)增加了 将对路易斯安那州特有的抗菌素耐药性数据进行趋势分析。

NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens Agency Funding Opportunity Number: PAR-16-099 Louisiana Project Summary The excessive use of antibiotics in food animals can lead to the presence of antibiotic resistant bacteria in retail meat products. This in turn can lead to antibiotic resistant infections in humans. The retail meat program monitors trends in antibiotic resistance in retail meat items. The staff from IDES will purchase 80 retail meat samples per month split into two sampling trips of 5 stores per trip. The following will be purchased from each store: 5 chicken parts, 2 ground turkey, 1 pork chop, 1 ground beef. Different brands of the same commodity are to be purchased at each store. If that is not possible, items with different lot codes or sell by dates will be purchased. The items will be purchased from the stores on the grocery store sampling list. The meat samples will be transported to the State Public Health Laboratory in Baton Rouge for processing and testing per protocol. Isolated Salmonella and Campylobacter will be shipped to FDA for NARMS testing. PFGE will be performed on Salmonella isolates at the State Lab and patterns will be uploaded to PulseNet. IDES staff and laboratorian will maintain the NARMS logsheets and submit them to FDA. They will also maintain the FDA quarterly results on Louisiana isolates and compare them to Louisiana results for accuracy and quality control. For the first 12 months of this grant cycle, the expected outcomes are the continuation of purchasing, processing, and testing 80 meat samples per month and the continuation of shipping isolates to FDA for NARMS testing. Expected outputs include a decrease in the turn-around time from Salmonella isolation to upload of patterns to PulseNet and an increase in antibiotic resistant data on Salmonella and Campylobacter to be used with other states' data at FDA. Over the five year project period, the expected outputs are a successful retail meat program for the State of Louisiana and quality retail meat surveillance data for FDA NARMS to use in addition to the data they receive from other states. This increase in quality data can help influence policy regarding antimicrobial use. The expected outcomes for the five year period includes: 1) the successful completion of the purchasing, processing, and testing of 80 meat samples per month. 2) Decreased turn-around time from Salmonella isolation to testing at the State PFGE lab and pattern upload to PulseNet which could lead to an increase in the outbreaks investigated and solved associated with Salmonella in retail meat products. 3) The increase in antimicrobial resistance data specific to Louisiana will be analyzed for trends.